{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:10:16Z","timestamp":1793243416941,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ruesch Center for the Cure of Gastrointestinal Cancers"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA051008"],"award-info":[{"award-number":["P30CA051008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001409"],"award-info":[{"award-number":["UL1TR001409"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00280-018-3533-8","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T22:20:29Z","timestamp":1517437229000},"page":"587-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies"],"prefix":"10.1007","volume":"81","clinical-trial-number":[{"clinical-trial-number":"nct02353026","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-1553","authenticated-orcid":false,"given":"John F.","family":"Deeken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita K.","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Smaglo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu Ruth","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Luecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Y.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pishvaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"5","key":"3533_CR1","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1128\/AAC.37.5.1108","volume":"37","author":"SR Meshnick","year":"1993","unstructured":"Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y (1993) Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother 37(5):1108\u20131114","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3533_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4269\/ajtmh.1994.50.777","volume":"50","author":"AJ Lin","year":"1994","unstructured":"Lin AJ, Ager AL Jr, Klayman DL (1994) The antimalarial activity of dihydroartemisinin derivatives by transdermal application. Am J Trop Med Hyg 50(6):777\u2013783","journal-title":"Am J Trop Med Hyg"},{"key":"3533_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","volume":"91","author":"H Lai","year":"1995","unstructured":"Lai H, Singh NP (1995) Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91:41\u201346","journal-title":"Cancer Lett"},{"key":"3533_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(06)80014-5","volume":"98","author":"H Moore Lai","year":"1995","unstructured":"Moore Lai H, Li JR, Ren RL, McDougall JA, Singh NP, Choud CK (1995) Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett 98:83\u201387","journal-title":"Cancer Lett"},{"key":"3533_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijpharm.2007.09.003","volume":"354","author":"I Nakase","year":"2008","unstructured":"Nakase I, Lai H, Singh NP, Sasaki T (2008) Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 354:28\u201333","journal-title":"Int J Pharm"},{"issue":"17","key":"3533_CR6","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","volume":"14","author":"J Hou","year":"2008","unstructured":"Hou J, Wang D, Zhang R, Wang H (2008) Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 14(17):5519\u20135530","journal-title":"Clin Cancer Res"},{"key":"3533_CR7","first-page":"1231","volume":"4","author":"T Efferth","year":"2003","unstructured":"Efferth T, Briehl MM, Tome ME (2003) Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 4:1231\u20131235","journal-title":"Int J Oncol"},{"issue":"3","key":"3533_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","volume":"48","author":"HH Chen","year":"2003","unstructured":"Chen HH, Zhou HJ, Fang X (2003) Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res 48(3):231\u2013236","journal-title":"Pharmacol Res"},{"issue":"9","key":"3533_CR9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.bcp.2003.12.035","volume":"67","author":"T Efferth","year":"2004","unstructured":"Efferth T, Ramirez T, Gebhart E, Halatsch ME (2004) Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochem Pharmacol 67(9):1689\u20131700","journal-title":"Biochem Pharmacol"},{"issue":"2A","key":"3533_CR10","first-page":"495","volume":"24","author":"B Rinner","year":"2004","unstructured":"Rinner B, Siegl V, P\u00fcrstner P, Efferth T, Brem B, Greger H, Pfragner R (2004) Activity of novel plant extracts against medullary thyroid carcinoma cells. Anticancer Res 24(2A):495\u2013500","journal-title":"Anticancer Res"},{"key":"3533_CR11","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","volume":"68","author":"R Dell\u2019Eva","year":"2004","unstructured":"Dell\u2019Eva R, Pfeffer U, Ven\u00e9 R, Anfosso L, Forlani A, Albini A, Efferth T (2004) Inhibition of angiogenesis in vivo and growth of Kaposi\u2019s sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 68:2359\u20132366","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3533_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/hed.20524","volume":"29","author":"W Nam","year":"2007","unstructured":"Nam W, Tak J, Ryu JK, Jung M, Yook JI, Kim HJ, Cha IH (2007) Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 29(4):335\u2013340","journal-title":"Head Neck"},{"issue":"2\u20133","key":"3533_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","volume":"47","author":"HJ Zhou","year":"2007","unstructured":"Zhou HJ, Wang WQ, Wu GD, Lee J, Li A (2007) Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol 47(2\u20133):131\u2013138","journal-title":"Vascul Pharmacol"},{"issue":"7","key":"3533_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1745-7254.2007.00612.x","volume":"28","author":"Y Jiao","year":"2007","unstructured":"Jiao Y, Ge CM, Meng QH, Cao JP, Tong J, Fan SJ (2007) Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin 28(7):1045\u20131056","journal-title":"Acta Pharmacol Sin"},{"key":"3533_CR15","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","volume":"2","author":"T Efferth","year":"2007","unstructured":"Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M (2007) Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2:e693","journal-title":"PLoS One"},{"issue":"3","key":"3533_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bcp.2009.04.014","volume":"78","author":"M Youns","year":"2009","unstructured":"Youns M, Efferth T, Reichling J, Fellenberg K, Bauer A, Hoheisel JD (2009) Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells. Biochem Pharmacol 78(3):273\u2013283","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3533_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12185-009-0409-z","volume":"90","author":"S Li","year":"2009","unstructured":"Li S, Xue F, Cheng Z, Yang X, Wang S, Geng F, Pan L (2009) Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2\/0 myeloma cells through affecting NFkappaB p65. Int J Hematol 90(4):513\u2013521","journal-title":"Int J Hematol"},{"issue":"5","key":"3533_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","volume":"65","author":"JH Du","year":"2010","unstructured":"Du JH, Zhang HD, Ma ZJ, Ji KM (2010) Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother Pharmacol 65(5):895\u2013902","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"3533_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bcp.2009.08.013","volume":"79","author":"M Michaelis","year":"2010","unstructured":"Michaelis M, Kleinschmidt MC, Barth S, Rothweiler F, Geiler J, Breitling R, Mayer B, Deubzer H, Witt O, Kreuter J, Doerr HW, Cinatl J, Cinatl J Jr (2010) Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharmacol 79(2):130\u2013136","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"3533_CR20","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/ijc.25315","volume":"127","author":"SA Rasheed","year":"2010","unstructured":"Rasheed SA, Efferth T, Asangani IA, Allgayer H (2010) First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer 127(6):1475\u20131485","journal-title":"Int J Cancer"},{"issue":"4","key":"3533_CR21","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.3390\/molecules15042886","volume":"15","author":"S Sertel","year":"2010","unstructured":"Sertel S, Eichhorn T, Simon CH, Plinkert PK, Johnson SW, Efferth T (2010) Pharmacogenomic identification of c-Myc\/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines. Molecules 15(4):2886\u20132910","journal-title":"Molecules"},{"issue":"8","key":"3533_CR22","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","volume":"286","author":"A Hamacher-Brady","year":"2011","unstructured":"Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, Efferth T, Eils R, Brady NR (2011) Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem 286(8):6587\u20136601","journal-title":"J Biol Chem"},{"issue":"1","key":"3533_CR23","first-page":"279","volume":"39","author":"O Thanaketpaisarn","year":"2011","unstructured":"Thanaketpaisarn O, Waiwut P, Sakurai H, Saiki I (2011) Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-\u03baB and PI3K\/Akt signaling pathways. Int J Oncol 39(1):279\u2013285","journal-title":"Int J Oncol"},{"key":"3533_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2298\/AOO0204279S","volume":"10","author":"NP Singh","year":"2002","unstructured":"Singh NP, Verma KB (2002) Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Oncol 10:279\u2013280","journal-title":"Arch Oncol"},{"issue":"6","key":"3533_CR25","first-page":"1599","volume":"14","author":"TG Berger","year":"2005","unstructured":"Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, Schuler G (2005) Artesunate in the treatment of metastatic uveal melanoma\u2014first experiences. Oncol Rep 14(6):1599 \u2013 603","journal-title":"Oncol Rep"},{"key":"3533_CR26","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1074\/jbc.M610375200","volume":"282","author":"AE Mercer","year":"2007","unstructured":"Mercer AE, Maggs JL, Sun XM, Cohen GM, Chadwick J, O\u2019Neill PM, Park BK (2007) Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J Biol Chem 282:9372\u20139382","journal-title":"J Biol Chem"},{"issue":"11","key":"3533_CR27","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","volume":"68","author":"PC Li","year":"2008","unstructured":"Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T (2008) Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 68(11):4347\u20134351","journal-title":"Cancer Res"},{"issue":"2","key":"3533_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1074\/jbc.M110.144188","volume":"286","author":"AE Mercer","year":"2011","unstructured":"Mercer AE, Copple IM, Maggs JL, O\u2019Neill PM, Park BK (2011) The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials. J Biol Chem 286(2):987\u2013996","journal-title":"J Biol Chem"},{"issue":"23","key":"3533_CR29","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","volume":"65","author":"GL Disbrow","year":"2005","unstructured":"Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R (2005) Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res 65(23):10854\u201310861","journal-title":"Cancer Res"},{"key":"3533_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1124\/mol.64.2.382","volume":"64","author":"T Efferth","year":"2003","unstructured":"Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, Ross DD, Funk JO (2003) Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64:382\u2013394","journal-title":"Mol Pharmacol"},{"issue":"8","key":"3533_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.micron.2009.07.001","volume":"40","author":"L Wang","year":"2009","unstructured":"Wang L, Chen T, Qu J, Wei X (2009) Quantitative analysis of caspase-3 activation by fitting fluorescence emission spectra in living cells. Micron 40(8):811\u2013820","journal-title":"Micron"},{"issue":"6","key":"3533_CR32","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/ijc.22804","volume":"121","author":"LN Li","year":"2007","unstructured":"Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX (2007) Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway. Int J Cancer 121(6):1360\u20131365","journal-title":"Int J Cancer"},{"issue":"1","key":"3533_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/156800909787314020","volume":"9","author":"VB Konkimalla","year":"2009","unstructured":"Konkimalla VB, McCubrey JA, Efferth T (2009) The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate\u2019s activity in cancer cells. Curr Cancer Drug Targ 9(1):72\u201380","journal-title":"Curr Cancer Drug Targ"},{"issue":"6","key":"3533_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00432-009-0731-0","volume":"136","author":"H Chen","year":"2010","unstructured":"Chen H, Sun B, Wang S, Pan S, Gao Y, Bai X, Xue D (2010) Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB. J Cancer Res Clin Oncol 136(6):897\u2013903","journal-title":"J Cancer Res Clin Oncol"},{"key":"3533_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00280-003-0751-4","volume":"53","author":"HH Chen","year":"2004","unstructured":"Chen HH, Zhou HJ, Wang WQ, Wu GD (2004) Antimalarial dihydroartemisinin also inhibits angiogenesis. Cancer Chemother Pharmacol 53:423\u2013432","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"3533_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.tpj.6500371","volume":"6","author":"L Anfosso","year":"2006","unstructured":"Anfosso L, Efferth T, Albini A, Pfeffer U (2006) Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenom J 6(4):269\u2013278","journal-title":"Pharmacogenom J"},{"issue":"1","key":"3533_CR37","first-page":"149","volume":"35","author":"S Sieber","year":"2009","unstructured":"Sieber S, Gdynia G, Roth W, Bonavida B, Efferth T (2009) Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate. Int J Oncol 35(1):149\u2013158","journal-title":"Int J Oncol"},{"issue":"3","key":"3533_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00280-017-3251-7","volume":"79","author":"A Bhaw-Luximon","year":"2017","unstructured":"Bhaw-Luximon A, Jhurry D (2017) Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives. Cancer Chemother Pharmacol 79(3):451\u2013466","journal-title":"Cancer Chemother Pharmacol"},{"key":"3533_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0140-6736(93)90362-K","volume":"341","author":"TT Hien","year":"1993","unstructured":"Hien TT, White NJ (1993) Qinghaosu Lancet 341:603\u2013608","journal-title":"Qinghaosu Lancet"},{"key":"3533_CR40","unstructured":"U.S. Army Medical Material Development Activity (2012) Intravenous Artesunate for Severe Malaria (IND No. 64,769), Investigator Brochure"},{"key":"3533_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","volume":"366","author":"A Dondorp","year":"2005","unstructured":"Dondorp A, Nosten F, Stepniewska K, Day N, White N (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717\u2013725","journal-title":"Lancet"},{"key":"3533_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/375059","volume":"37","author":"PN Newton","year":"2003","unstructured":"Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, Teerapong P, Suputtamongkol Y, Looareesuwan S, White NJ (2003) Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 37:7\u201316","journal-title":"Clin Infect Dis"},{"key":"3533_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0035-9203(01)90157-9","volume":"95","author":"E Leonardi","year":"2001","unstructured":"Leonardi E, Gilvary G, White NJ, Nosten F (2001) Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg 95:182\u2013183","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"3533_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2165\/00003495-199550040-00009","volume":"50","author":"LB Barradell","year":"1995","unstructured":"Barradell LB, Fitton A (1995) Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 50(4):714\u2013741","journal-title":"Drugs"},{"issue":"9","key":"3533_CR45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1124\/dmd.30.9.1005","volume":"30","author":"KF Ilett","year":"2002","unstructured":"Ilett KF, Ethell BT, Maggs JL, Davis TM, Batty KT, Burchell B, Binh TQ, Thu le TA, Hung NC, Pirmohamed M, Park BK, Edwards G (2002) Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos 30(9):1005\u20131012","journal-title":"Drug Metab Dispos"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-018-3533-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-018-3533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:05:58Z","timestamp":1628589958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-018-3533-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3533"],"URL":"https:\/\/doi.org\/10.1007\/s00280-018-3533-8","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author John Deeken declares he has no conflict of interest. Author Hongkun Wang declares she has no conflict of interest. Author Marion Hartley declares she has no conflict of interest. Author Amrita K. Cheema declares she has no conflict of interest. Author Brandon Smaglo declares he has no conflict of interest. Author Jimmy J. Hwang declares he has no conflict of interest. Author Aiwu Ruth He declares she has no conflict of interest. Author Louis M. Weiner declares he has no conflict of interest. Author John L. Marshall declares he has no conflict of interest. Author Giuseppe Giaccone declares he has no conflict of interest. Author Stephen Liu declares he has no conflict of interest. Author Jim Luecht declares he has no conflict of interest. Author Jay Y. Spiegel declares he has no conflict of interest. Author Michael J. Pishvaian declares he has no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}